Bronchiectasis
Conditions
Keywords
Prognosis, Prospective Study, Quality of Life, Radiology, Rehabilitation, Registry;, Signs and Symptoms, Therapy, Bronchiectiasis, Diagnosis, Epidemiology, Etiology, Longitudinal Study, Microbiology
Brief summary
The purpose of this study is to study the epidemiology of non-CF bronchiectasis (NCFB) and to provide an estimate of the distribution (prevalence) of NCFB etiologies across all different levels of health care as well as real-life data regarding the current management of NCFB in Germany.
Detailed description
* To study the epidemiology of non-CF bronchiectasis (NCFB) and to provide an estimate of the distribution (prevalence) of NCFB etiologies across all different levels of health care as well as real-life data regarding the current management of NCFB in Germany * To establish feasible investigational strategies in order to establish the etiology of NCFB * To perform observational research into bronchiectasis, particularly in areas where single center datasets are underpowered, such as in rare etiologies or determining markers of prognosis * To promote collaborative clinical, basic and translational research in NCFB between German (and European) centers * To provide a registry of well phenotyped patients with NCFB in clinical centers potentially eligible for enrolment into clinical trials * To track access to healthcare and cost of caring for patients with NCFB over time
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* A clinical history consistent with bronchiectasis * (High resolution) computed tomography (CT) scan of the chest demonstrating bronchiectasis affecting 1 or more lobes
Exclusion criteria
* Bronchiectasis due to known cystic fibrosis (CF) * Age \<18 years * Interstitial lung disease * Prior lung or heart-lung transplantation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants with non-CF bronchiectasis (NCFB) across all different levels of health care regarding the current management of NCFB in Germany | three years | To establish a national, representative, prospective, observational and longitudinal NCFB database and collaborative research network with a database including a minimum of 750 patients from a minimum of 25 centers from all levels of healthcare across Germany after a period of 3 years. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of non-CF bronchiectasis (NCFB) etiologies (composite outcome measures) across all different levels of health care | three years | * Distribution (prevalence) of underlying conditions/etiologies * Clinical presentation of NCFB * Predictors of lung function decline in patients with NCFB * Diagnostics employed in determining the etiology of NCFB * Microbiology of NCFB * Radiology of NCFB * Comorbidity in patients with NCFB * Impact of exacerbations and hospitalizations on the clinical course of NCFB * Prescription patterns of pharmacological respiratory treatments for NCFB * Usage and benefit of surgical procedures in NCFB * Physical therapy and rehabilitation * Healthcare utilization and associated costs in NCFB * QOL(Questions of Life) among patients with NCFB * survival/mortality of NCFB |
Countries
Germany